Cell death at the millennium. Implications for liver diseases

N Kaplowitz1

  • 1University of Southern California Research Center for Liver Diseases, Los Angeles, California.

Insights

Cell death, through apoptosis or necrosis, involves mitochondria and shares common triggers. Mitochondrial function determines the cell death outcome, impacting liver disease and therapeutic strategies.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pathology

Background:

  • Cell death occurs via apoptosis or necrosis, morphologically distinct but sharing initiating events like receptor ligation, chemicals, hypoxia, and oxidative stress.
  • Mitochondria play a crucial role in both apoptosis and necrosis, with their functional collapse dictating the cell death pathway.
  • Both apoptosis and necrosis are implicated in the pathogenesis of most liver diseases.

Purpose of the Study:

  • To elucidate the shared initiating events and mitochondrial involvement in apoptosis and necrosis.
  • To understand how mitochondrial functional collapse determines the specific mode of cell death.
  • To explore the therapeutic potential of targeting various components of cell death pathways in liver diseases.

Main Methods:

  • The study likely involved analyzing cellular and biochemical markers of apoptosis and necrosis.
  • Investigated the role of mitochondria in regulating ATP levels and cytochrome c release.
  • Examined the impact of targeting specific cell death pathway components (death receptors, caspases, mitochondria) in preclinical models of liver disease.

Main Results:

  • Identified common initiating events for apoptosis and necrosis, highlighting the central role of mitochondria.
  • Demonstrated that the extent of mitochondrial dysfunction dictates whether cells undergo apoptosis (via caspase activation) or necrosis (via ATP loss and lysis).
  • Showcased promising therapeutic potential for targeting death receptors, initiator caspases, and mitochondria in liver diseases.

Conclusions:

  • Mitochondrial integrity is a critical determinant of cell death fate, influencing liver disease progression.
  • Targeting upstream components of cell death pathways offers therapeutic promise for liver diseases.
  • Inhibiting executioner caspases may shift cell death from apoptosis to necrosis, with implications for treatment strategies.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
188
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.4K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
4.2K